These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
386 related items for PubMed ID: 21625223
1. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations. Rowh MA, DeMicco A, Horowitz JE, Yin B, Yang-Iott KS, Fusello AM, Hobeika E, Reth M, Bassing CH. Oncogene; 2011 Nov 24; 30(47):4757-64. PubMed ID: 21625223 [Abstract] [Full Text] [Related]
2. Somatic inactivation of Tp53 in hematopoietic stem cells or thymocytes predisposes mice to thymic lymphomas with clonal translocations. DeMicco A, Yang-Iott K, Bassing CH. Cell Cycle; 2013 Oct 15; 12(20):3307-16. PubMed ID: 24036547 [Abstract] [Full Text] [Related]
10. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene. Fiancette R, Rouaud P, Vincent-Fabert C, Laffleur B, Magnone V, Cogné M, Denizot Y. J Immunol; 2011 Dec 01; 187(11):5772-82. PubMed ID: 22039300 [Abstract] [Full Text] [Related]
11. Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas. Schmitz R, Renné C, Rosenquist R, Tinguely M, Distler V, Menestrina F, Lestani M, Stankovic T, Austen B, Bräuninger A, Hansmann ML, Küppers R. Leukemia; 2005 Aug 01; 19(8):1452-8. PubMed ID: 15973455 [Abstract] [Full Text] [Related]
12. Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching. Wang JH, Alt FW, Gostissa M, Datta A, Murphy M, Alimzhanov MB, Coakley KM, Rajewsky K, Manis JP, Yan CT. J Exp Med; 2008 Dec 22; 205(13):3079-90. PubMed ID: 19064702 [Abstract] [Full Text] [Related]
13. Role of the translocation partner in protection against AID-dependent chromosomal translocations. Jankovic M, Robbiani DF, Dorsett Y, Eisenreich T, Xu Y, Tarakhovsky A, Nussenzweig A, Nussenzweig MC. Proc Natl Acad Sci U S A; 2010 Jan 05; 107(1):187-92. PubMed ID: 19966290 [Abstract] [Full Text] [Related]
15. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Robbiani DF, Bunting S, Feldhahn N, Bothmer A, Camps J, Deroubaix S, McBride KM, Klein IA, Stone G, Eisenreich TR, Ried T, Nussenzweig A, Nussenzweig MC. Mol Cell; 2009 Nov 25; 36(4):631-41. PubMed ID: 19941823 [Abstract] [Full Text] [Related]
18. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis. Yu D, Thomas-Tikhonenko A. Oncogene; 2002 Mar 14; 21(12):1922-7. PubMed ID: 11896625 [Abstract] [Full Text] [Related]
19. Mechanisms that can promote peripheral B-cell lymphoma in ATM-deficient mice. Tepsuporn S, Hu J, Gostissa M, Alt FW. Cancer Immunol Res; 2014 Sep 14; 2(9):857-66. PubMed ID: 24913718 [Abstract] [Full Text] [Related]
20. Oncogenic events triggered by AID, the adverse effect of antibody diversification. Pérez-Durán P, de Yebenes VG, Ramiro AR. Carcinogenesis; 2007 Dec 14; 28(12):2427-33. PubMed ID: 17804422 [Abstract] [Full Text] [Related] Page: [Next] [New Search]